Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake Status

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Breast Cancer

In brief

This clinical trial aims to evaluate the efficacy and safety of Dexmedetomidine Hydrochloride Nasal Spray for conscious sedation and anxiety relief during breast-conserving surgery. The main questions it aims to answer are: Does Dexmedetomidine Hydrochloride Nasal Spray effectively provide intraoperative sedation and improve postoperative awakening time? What changes in vital signs or postoperative complications do participants experience when using this medication? Researchers will compare Dexmedetomidine Hydrochloride Nasal Spray to a placebo (saline nasal spray) to determine its efficacy in breast-conserving surgery. Participants will: Receive preoperative administration of either Dexmedetomidine Hydrochloride Nasal Spray or the placebo nasal spray; Undergo regular intraoperative and postoperative assessments, including sedation scores, awakening time, and pain scores; Provide satisfaction feedback and be monitored for changes in vital signs and complications.

Key facts

Study ID

NCT07350928

Run by

Tianjin Medical University Cancer Institute and Hospital

People needed

394

Starts

2025-03-01

Expected to finish

2026-03-01

Last updated by the study team

2026-01-20

Who can join

Age: 20 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Sign the informed consent for
• The patients included in the study were women aged between 20 and 70.
• ASA (American Society of Anesthesiologists) I-II.
• BMI:18-26 Kg/m ²

You may not qualify if…

• Subjects deemed unsuitable for nasal spray administration by the researchers (such as those with severe rhinitis, nasal deformities, etc.);
• Severe bradycardia (HR < 50 beats/min), history of cardiac conduction block;
• History of upper respiratory tract infection;
• History of asthma;
• History of allergy to DEX or local anesthetics;
• Subjects who have taken anti-anxiety medication before the operation;
• Subjects with a history of ischemic stroke or transient ischemic attack;
• Subjects with poorly controlled blood pressure despite medication;
• Subjects with a history of mental illness, cognitive impairment, or epilepsy;
• Subjects with a history of pregnancy;
• Subjects who have been taking sedatives or analgesics for a long time;
• Subjects with a history of liver or kidney function impairment;
• Subjects with a history of drug or alcohol abuse;
• Other situations that the reviewers consider to be disqualifying based on the registration study, such as potential non-compliance with the clinical protocol.

Where it is running

• Tianjin Medical University Cancer Institute and Hospital — Tianjin, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.